ScienceDaily: Mind & Brain News

Researchers have found that some people with schizophrenia have autoantibodies -- which are made by the immune system and recognize the body's own proteins, rather than outside threats such as viruses or bacteria -- against NCAM1, a protein that's important for communication between brain cells. The patients' autoantibodies also caused schizophrenia-related behaviors in mice. These findings may improve the diagnosis and treatment of a subset of patients with schizophrenia.

Pandemic-era changes to prescribing guidelines for the lifesaving drug buprenorphine led to improved treatment outcomes for patients with opioid use disorder in Philadelphia, according to a recently published study.